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When pH]inositol-prelabeled cultured bovine adrenal chromallin cells were stimulated with nicotine (10 GM), a large and transient increase in PHI- 
inositol pentakisphosphate (InsP,) accmnulation was observed. The accumulation reached the maximum level at 15 s, then declined to the basal 
level at 2 min. Nicotine also induced PH]inositol tetrakisphosphate (InsP,) and PH]inositol hexakisphosphate (InsP,) accumulation with a slower 
time course and a lesser magnitude than PH]InsP,. The peaks of PH]InsP,, PH]InsP, and PH]InsP, coincided with those of 3zP radioactivity, when 
cells were doubly labeled with PH]inositol and inorganic 3zP. These results suggest hat inositol pentakisphosphate is rapidly increased by nicotine, 
a cholinergic agonist, in cultured adrenal chromaffin cells. 
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1. INTRODUCTION 2.2. Measurement of inositol phosphate accumulation 
Inositol trisphosphates (InsP3) are well-established 
second messengers for Ca2+ release from the en- 
doplasmic reticulum [l-3]. Inositol tetrakisphosphates 
(InsP4) appear to mediate Ca2+ sequestration [4], Ca2+ 
influx [5,6] and membrane current activities [7,8]. In- 
ositol pentakisphosphates (InsPs) exist in mammalian 
cell types [6,9-121, but have been considered as a 
‘housekeeping’ inositol phosphate rather than an acute 
second messenger [2]. Therefore, the regulation of 
biosynthesis and the function remain to be explored. 
Vallejo et al. [12] have shown that exogenously added 
InsPs regulates blood pressure via the central nervous 
system. This raises the possibility that InsPs biosyn- 
thesis is finely regulated by stimulations of hormones 
and neurotransmitters. We report here that nicotinic 
receptor stimulation induces a rapid and large increase 
in InsPs in adrenal chromaffin cells. 
The cells were labeled with [3H]inositol (50&i/ml) in 35-mm 
diameter dishes for 2 days, as described previously [14-17,201. In 
some experiments, they were double-labeled with [“2P]HjP04 
(50 &i/ml) and [‘Hlinositol (50 &i/ml). The culture medium was 
aspirated and was replaced by Locke’s solution, consisting of (in 
mM): 154 NaCl, 5.6 KCI, 2 CaC12, 1 MgCl2, 3.6 NaHCOs, 5.6 
glucose, 10 Hepes and 0.1% bovine serum albumin (pH 7.4). The cell 
sheets were washed 3 times with Locke’s solution. The cells were 
preincubated at 37°C for 20 min in 10 mM LiCl-containing Locke’s 
solution. Nicotine solution was added to the incubation mixture and 
the cells were incubated for various periods. At the end of the incuba- 
tion, the Locke’s solution was aspirated and inositol phosphates were 
extracted as described previously [ 14- 17,201. Isomers of inositol 
polyphospates were separated by high-performance anion exchange 
chromatography according to the method of Balla et al. [18]. In 
brief, the samples were subjected to HPLC with an Adsorbosphere 
SAX S-pm column (Alltech Applied Science Labs) and a linear gra- 
dient (1% increaselmin) of ammonium phosphate (PH 3.35, with 
phosphoric acid at 25”C), at a flow rate of 1 ml/min. The effluent 
radioactivity was monitored by an on-line flow detector (Packard 
Japan, Tokyo, Japan). 
2.3. Chemicals 
2. EXPERIMENTAL 
2.1. Primary culture of bovine adrenal chromaffin cells 
Chromaffin cells were isolated from fresh bovine adrenal medulla 
as described previously [14,15]. The chromaffin cells were purified by 
differential plating [15] and were plated on 35-mm diameter dishes 
(2.5 x lo6 cells/dish) in 3 ml of minimum essential medium (Gibco; 
Gland Island, NY), supplemented with 10% fetal calf serum 
(Hyclone; Logan, UT). The purity of chromaffin cells was over 95%. 
They were cultured at 37°C in an atmosphere of 95% sir/5% COZ. 
The chromaffin cells were used for experiments 5days after plating. 
The following chemicals were obtained from the companies in- 
dicated: myo-[2-‘Hlinositol (17 Ci/mmol), [32P]H3P04 from Amer- 
sham International, Buckinghamshire, England; myo-[1-‘Hlinositol 
1,4,5_trisphosphate (17 CVmmol), myo-[1-‘Hlinositol 1,3,4-tris- 
phosphate (17 Ci/mmol), myo-[1-‘Hlinositol 1,3,4,5_tetrakisphos- 
phate (17 Ci/mmol), myo-[2-‘Hlinositol hexakisphosphate (12 Ci/ 
mmol) from New England Nuclear, Boston, MA. The standard of 
[‘H]Ins(1,3,4,5,6)Ps was generously given by Dr P.T. Hawkins, 
Department of Cellular Pharmacology, Smith Kline and French 
Research, The Frythe, Welwyn, Herts, England. 
Correspondence address: N. Sasakawa, Department of Phar- 
macology, Keio University School of Medicine, 35 Shinanomachi, 
Shinjuku-ku, Tokyo, Japan 
3. RESULTS AND DISCUSSION 
[3H]Ins(l,4,5)P3 and [3H]Ins(1,3,4)P3 were eluted at 
0.3 M ammonium phosphate (fig.1) under the condi- 
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Fig. 1. Elution profile of [‘Hlinositol phosphates produced in intact 
adrenal chromaffin cells and separated by high-performance anion 
exchange chromatography. Upper panel, basal levels. Lower panel, 
stimulation by 10 PM nicotine. Each [3H]inositol phosphate standard 
was eluted from the column as one major peak at indicated positions 
(-). Typical data obtained from 5 different cell preparations are 
presented. 
tions we used, consistent with the results of Balla et al. 
[ 181, who used a similar gradient. The peak at 0.5 M 
ammonium phosphate was considered as [3H]InsP4, 
since the standard, [3H]Ins(1,3,4,5)P4, was eluted at the 
same retention time and Balla et al. also observed 
[3H]InsP4 in the identical position [18]. The peak at 
0.6 M ammonium phosphate was considered as 
[3H]InsP5; first, the retention time was identical with 
, 
- T 
I : 
__-- e--_ I 
__-- I 
Y 5 _____---- 
_-- 
- 0.5 
& 
A 
i;; - - z 
_ E 
g:- - - _ 
z : lns(1.3.4.5.6)P~ InsPg hlS(1,3,4,5)P4 
; I 
3H 
- 0 
r __-- _-- 
: 2 
i= 
2 
__-- f 
g 1 -___---*--- -0.5 2 
d 1 
H 
a 
0 1 
55 60 65 70 75 80 
RETENTION TIME (min) 
Fig.2. Elution profile of [3H]InsP4, [‘H]InsPT and [‘H]InsPe labeled 
with “P and produced in intact adrenal chromaffin cells. Intact 
chromaffin cells were labeled with 50 &i/ml myo-[2-‘Hlinositol and 
50 &i/ml [32P]H3P04 for 2 days. Under these conditions, 32P counts 
with the retention time corresponded to Ins(1,3,4)Pr and Ins(1,4,5)P3 
contained many peaks and could not be assigned to each InsPr peak. 
Data from unstimulated cells are shown. Each [‘Hlinositol phosphate 
standard was eluted from the column as one major peak at indicated 
positions (-). Upper panel, 32P radioactivity. Lower panel, ‘H 
radioactivity. Typical data obtained from two different cell 
preparations are presented. 
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Fig.3. Time course of [‘H]InsPs, [‘H]InsP4, [‘H]InsPS and [‘H]InsPa 
accumulation in intact adrenal chromaffin cells. Upper panels, basal 
levels. Lower panels, stimulation by 10 pM nicotine. The experiments 
were repeated twice and gave similar results. 
that of a standard, [3H]Ins(l,3,4,5,6)P5. Second, this 
3H peak coincided with that of 32P (fig.2). The more 
polar [3H]inositol- and 32P-containing material may be 
[3H]InsPh, since the standard, [3H]InsPe, was eluted at 
the same position. 
Stimulation with nicotine increased InsP3 in the 
chromaffin cells (fig.3), consistent with previous 
reports [ 14,17,19]. Nicotine induced a large and rapid 
increase in InsPS, which peaked at 15 s after stimula- 
tion. This suggests the presence of active degradative 
pathways as well as the stimuli-sensitive productive 
ones. InsP4 and InsP,j were also increased with a slower 
time course and lesser magnitude than InsPS. Recently, 
Pittet et al. [21] have reported that InsPs is ac- 
cumulated by chemotactic peptides in HL60 cells. 
However, in HL60 cells, the InsPs accumulation occurs 
more slowly than Ins(1,4,5)P3 does. In chromaffin 
cells, the agonist-stimulated increase in Ins( 1,4,5)P3 is 
small [14,15,17]. In fact, InsPs is the most pronounced 
inositol phosphate identified so far in the chromaffin 
cells. Furthermore, the time course was comparable to 
Ins(1,4,5)P3. A current hypothesis proposes that InsPs 
is formed by phosphorylation of InsP4 [22,23]. Alter- 
natively, it is possible that InsP5 is generated in- 
dependently of InsP4 formation, although more 
rigorous research is necessary for establishing this 
possibility. Although inositol pentakisphospate- 
containing phospholipids have not been shown, it is 
possible that such phospholipids exist in mammalian 
plasma membranes, as Heslop et al. [9] discussed. 
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